BSG and liver cancer: This conditional Ab has three advantages: hypoxia‐dependent selective targeting to CD147 Ag; lacks HcHAb18 Ab‐associated toxicity; potential as immunotherapeutic drug and for enhancing liver cancer imaging and inhibition.